357 related articles for article (PubMed ID: 23360737)
21. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
[TBL] [Abstract][Full Text] [Related]
22. Is intravenous iodinated contrast medium administration really harmful in hospitalized acute kidney injury patients: a propensity score-matched study.
Yan P; Zhang NY; Luo XQ; Wang M; Deng YH; Wu T; Wu X; Liu Q; Wang HS; Wang L; Kang YX; Duan SB
Eur Radiol; 2022 Feb; 32(2):1163-1172. PubMed ID: 34342692
[TBL] [Abstract][Full Text] [Related]
23. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
[TBL] [Abstract][Full Text] [Related]
24. Failure to demonstrate contrast nephrotoxicity.
Heller CA; Knapp J; Halliday J; O'Connell D; Heller RF
Med J Aust; 1991 Sep; 155(5):329-32. PubMed ID: 1895978
[TBL] [Abstract][Full Text] [Related]
25. Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT.
Dillman JR; al-Hawary M; Ellis JH; Cohan RH; Kaza R; Myles JD; Khalatbari S; Francis IR
AJR Am J Roentgenol; 2012 Feb; 198(2):392-7. PubMed ID: 22268183
[TBL] [Abstract][Full Text] [Related]
26. Low incidence of nephrotoxicity following intravenous administration of iodinated contrast media: a prospective study.
Castaldo P; Frascà GM; Brigante F; Ferrante L; Magi S; Pavani M; Skrami E; Giuseppetti GM; Polonara G; Amoroso S
Eur Radiol; 2019 Jul; 29(7):3927-3934. PubMed ID: 30989349
[TBL] [Abstract][Full Text] [Related]
27. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
28. Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study.
McDonald JS; McDonald RJ; Williamson EE; Kallmes DF
Radiology; 2017 Nov; 285(2):414-424. PubMed ID: 28708022
[TBL] [Abstract][Full Text] [Related]
29. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.
Langner S; Stumpe S; Kirsch M; Petrik M; Hosten N
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1525-9. PubMed ID: 18524974
[TBL] [Abstract][Full Text] [Related]
30. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
[TBL] [Abstract][Full Text] [Related]
31. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
32. Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study.
McDonald JS; McDonald RJ; Williamson EE; Kallmes DF; Kashani K
Intensive Care Med; 2017 Jun; 43(6):774-784. PubMed ID: 28213620
[TBL] [Abstract][Full Text] [Related]
33. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
34. Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods.
Davenport MS; Khalatbari S; Cohan RH; Ellis JH
Radiology; 2013 Oct; 269(1):92-100. PubMed ID: 23579047
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of contrast material-induced nephropathy in the era of hydration.
Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
[TBL] [Abstract][Full Text] [Related]
36. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
[TBL] [Abstract][Full Text] [Related]
37. Acute Kidney Injury After CT in Emergency Patients with Chronic Kidney Disease: A Propensity Score-matched Analysis.
Kene M; Arasu VA; Mahapatra AK; Huang J; Reed ME
West J Emerg Med; 2021 Apr; 22(3):614-622. PubMed ID: 34125036
[TBL] [Abstract][Full Text] [Related]
38. Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure.
McDonald JS; McDonald RJ; Lieske JC; Carter RE; Katzberg RW; Williamson EE; Kallmes DF
Mayo Clin Proc; 2015 Aug; 90(8):1046-53. PubMed ID: 26250726
[TBL] [Abstract][Full Text] [Related]
39. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Ng CS; Shaw AD; Bell CS; Samuels JA
AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
[TBL] [Abstract][Full Text] [Related]
40. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
